Epstein-Barr virus as a marker of biological aggressiveness in breast cancer
2011

Epstein-Barr Virus in Breast Cancer

Sample size: 196 publication Evidence: moderate

Author Information

Author(s): Mazouni C, Fina F, Romain S, Ouafik L, Bonnier P, Brandone J-M, Martin P-M

Primary Institution: Laboratoire de transfert d’oncologie biologique, Assistance Publique – Hôpitaux de Marseille, Faculté de Médecine Nord, Marseille, France

Hypothesis

EBV-infected breast cancer cells might behave differently compared to those negative for EBV.

Conclusion

EBV-positive breast cancers exhibit more aggressive features.

Supporting Evidence

  • EBV DNA was present in 33.2% of breast cancer cases studied.
  • EBV-positive tumors were more frequently estrogen receptor negative.
  • High histological grade was more common in EBV-positive breast cancers.

Takeaway

This study found that some breast cancers have a virus called Epstein-Barr, which makes them grow more aggressively.

Methodology

Real-time quantitative PCR was used to establish the frequency of EBV-infected breast cancer in 196 specimens.

Participant Demographics

Patients were recruited in Marseille, France, between May 1996 and December 1998.

Statistical Information

P-Value

P=0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6606048

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication